Cargando…
Regenerative effect of recombinant human bone morphogenetic protein-2/absorbable collagen sponge (rhBMP-2/ACS) after sequestrectomy of medication-related osteonecrosis of the jaw (MRONJ)
OBJECTIVES: Beyond the original application approved by the U.S. Food and Drug Administration, recombinant human bone morphogenetic protein-2 (rhBMP-2) is used for medication-related osteonecrosis of the jaw (MRONJ) treatment because of its bone remodeling enhancement properties. The purpose of the...
Autores principales: | Min, Song-Hee, Kang, No-Eul, Song, Seung-Il, Lee, Jeong-Keun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Oral and Maxillofacial Surgeons
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7338633/ https://www.ncbi.nlm.nih.gov/pubmed/32606280 http://dx.doi.org/10.5125/jkaoms.2020.46.3.191 |
Ejemplares similares
-
Immediate reconstruction of mandibular defect after treatment of medication-related osteonecrosis of the jaw (MRONJ) with rhBMP-2/ACS and miniplate: Review of 3 cases
por: Kim, Mu-seong, et al.
Publicado: (2019) -
The use of recombinant human bone morphogenetic protein-2 (rhBMP-2) in maxillofacial trauma
por: Herford, A.S.
Publicado: (2017) -
Imaging in Patients with Bisphosphonate-Associated Osteonecrosis of the Jaws (MRONJ)
por: Berg, Britt-Isabelle, et al.
Publicado: (2016) -
Role of Teriparatide in Medication-Related Osteonecrosis of the Jaws (MRONJ)
por: Kwon, Yong-Dae, et al.
Publicado: (2016) -
Off-label use of rhBMP-2
por: Watts, Clark
Publicado: (2011)